Measuring Pulmonary Artery Pressures in Heart Failure: A New Useful Diagnostic Tool?

Circulation

Volumn 135, Issue 16, 2017, Pages 1518-1521

  Gorter, Thomas M ^a   Rienstra, Michiel ^a   Van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

diagnostic techniques, cardiovascular; Editorials; pulmonary circulation

Indexed keywords

DIURETIC AGENT; VASODILATOR AGENT;

HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; LUNG ARTERY PRESSURE; LUNG CIRCULATION; LUNG CONGESTION; PRESSURE MEASUREMENT; PRIORITY JOURNAL; REVIEW; PROSTHESES AND ORTHOSES; PULMONARY ARTERY;

HEART FAILURE; HUMANS; PROSTHESES AND IMPLANTS; PULMONARY ARTERY;

EID: 85017518312     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.027668     Document Type: Review

References (14)

1. Blecker S, Paul M, Taksler G, Ogedegbe G, Katz S. Heart failure- associated hospitalizations in the United States. J Am Coll Cardiol. 2013;61:1259-1267. doi: 10.1016/j.jacc.2012.12.038.
2. Cohn JN, Mashiro I, Levine TB, Mehta J. Role of vasoconstrictor mechanisms in the control of left ventricular performance of the normal and damaged heart. Am J Cardiol. 1979;44:1019-1022.
3. Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Mel-drum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB; National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114:1883-1891. doi: 10.1161/CIRCULA-TIONAHA.106.632208.
4. Kuck KH, Bordachar P, Borggrefe M, Boriani G, Burri H, Leyva F, Schauerte P, Theuns D, Thibault B, Kirchhof P, Hasenfuss G, Dickstein K, Leclercq C, Linde C, Tavazzi L, Ruschitzka F; Document Reviewers. New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure As sociation. Europace. 2014;16:109-128. doi: 10.1093/euro-pace/eut311.
5. Kalogeropoulos AP, Siwamogsatham S, Hayek S, Li S, Deka A, Marti CN, Georgiopoulou VV, Butler J. Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients. J Am Heart Assoc. 2014;3:e000363. doi: 10.1161/JAHA.113.000363.
6. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS; CHAMPION Trial Study Group. Wireless pulmonary artery haemo-dynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011;377:658-666. doi: 10.1016/ S0140-6736(11)60101-3.
7. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129-2200. doi: 10.1093/ eurheartj/ehw128.
8. Heywood JT, Jermyn R, Shavelle D, Abraham WT, Bhimaraj A, Bhatt K, Sheikh F, Eichorn E, Lamba S, Bharmi R, Agarwal R, Kumar C, Stevenson LW. Impact of practice-based management of pulmonary artery pressures in 2000 patients implanted with the CardioMEMS sensor. Circulation. 2017;135:1509-1517. doi: 10.1161/CIRCULATIONAHA.116.026184.
9. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Red-field MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251-259. doi: 10.1056/NEJMoa052256.
10. van Veldhuisen DJ, Linssen GC, Jaarsma T, van Gilst WH, Hoes AW, Tijssen JG, Paulus WJ, Voors AA, Hillege HL. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol. 2013;61:1498-1506. doi: 10.1016/j.jacc.2012.12.044.
11. Adamson PB, Abraham WT, Bourge RC, Costanzo MR, Hasan A, Yadav C, Henderson J, Cowart P, Stevenson LW. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Circ Heart Fail. 2014;7:935-944. doi: 10.1161/CIRCHEARTFAIL-URE.113.001229.
12. Gorter TM, Hoendermis ES, van Veldhuisen DJ, Voors AA, Lam CS, Geelhoed B, Willems TP, van Melle JP. Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Eur J Heart Fail. 2016;18:1472-1487. doi: 10.1002/ejhf.630.
13. Hoendermis ES, Liu LC, Hummel YM, van der Meer P, de Boer RA, Berger RM, van Veldhuisen DJ, Voors AA. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial. Eur Heart J. 2015;36:2565-2573. doi: 10.1093/eurheartj/ehv336.
14. Hoeper MM, Lam CS, Vachiery JL, Bauersachs J, Gerges C, Lang IM, Bonderman D, Olsson KM, Gibbs JS, Dorfmuller P, Guazzi M, Galie N, Manes A, Handoko ML, Vonk-Noordegraaf A, Lankeit M, Konstan-tinides S, Wachter R, Opitz C, Rosenkranz S. Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research [published online ahead of print December 23, 2016]. Eur Heart J. doi: 10.1093/eurheartj/ehw597. https://academic.oup.com/eurheartj/article-abstract/doi/10.1093/ eurheartj/ehw597/2736258/Pulmonary-hypertension-in-heart-fail-ure-with?redirectedFrom=fulltext.Accessed December 28, 2016.